Japan
· Delayed Price · Currency is JPY CellSeed Company Description
CellSeed Inc. develops cell sheet regenerative medicines.
It is involved in the research, development, and commercialization of cell-sheet regenerative medicine products, such as epithelial cell sheet for esophageal regeneration, regenerated cartilage sheet, and chondrocyte sheet for the treatment of knee osteoarthritis.
The company also offers UpCell, a temperature-responsive cell cultureware for cell-sheet engineering; RepCell, a temperature-responsive cell cutureware for cell collection; and HydroCell, a low cell binding cultureware.
In addition, it provides peripheral equipment, including ThermoPlate III, a heating element made by a transparent glass plate; and cellZscope, an automated cell monitoring system, as well as contract development and manufacturing services.
The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
| Country | Japan |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 44 |
| CEO | Setsuko Hashimoto |
Contact Details
Address: Telecom Center Building Tokyo, 135-0064 Japan | |
| Phone | 81 3 6380 7490 |
| Website | cellseed.com |
Stock Details
| Ticker Symbol | 7776 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | JP3423530009 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Setsuko Hashimoto | Chief Executive Officer |
| Jun Onodera | Chief Financial Officer |